InFocus: Life Sciences & Healthcare e-newsletter - October 2011
Welcome to the October issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look at:
Features
- A unitary European patent and a unified European patent litigation system – Political agreement by the end of 2011?
- Cop out? – The European Commission closes competition investigation into alleged “misuse of the patent system” by Boehringer
- Promoting Your Business – A legal checklist
Case reports
- CJEU to rule on patentability of embryonic stem cells on 18 October – Oliver Brüstle v Greenpeace eV (CJEU case C-34/10)
- New SPC referral – a fresh perspective – Novartis v Actavis (CJEU case C-442/11)
- Parallel imports – naming the repackager on the box – Orifarm and Paranova v Merck Sharp & Dohme (CJEU cases C-400/09 and C-207/10)
- Advocate General's Opinion delivered in Medeva and Georgetown – Medeva (CJEU case C-322/10) and Georgetown University (CJEU case C-422/10)
- "Minicare" services to urologists? All sorts of confusion over "Omnicare" trade marks – Omnicare (CJEU cases T-289/09 and T-290/09)
Hot topics
- Parallel trade issues
- Biosimilars: Guidelines on non-clinical and clinical issues for authorising biosimilars to be revised
- Agency Workers: what should you do now?
- New VC tax relief proposals
- Takeover code amendments effective from 19 September 2011
- UK corporate tax reform: The Patent Box
- UK corporate tax reform: The CFC consultation
- Patent litigation procedure and practice across 30 European jurisdictions
- New Street Solutions: Financial Times recognises Taylor Wessing's innovative use of technology
Anwälte Helen Cline, Lee Bagshaw, William Belcher, Katie Bennett, Christoph de Coster, Nikol Davies, Mark Dennis, Rachel Farr, Peter Jackson, James Meakin, Sean Nesbitt, Timothy Pinto, John Plant, Matthew Royle, David Sant, James Stewart, Tim Stocks, Michelle Williamson, Tim Worden, Robert Young
